ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Decision-Making Among HCV-Negative Transplant Candidates Offered Organs from Donors with HCV Infection

E. Schnellinger1, E. Saine1, M. Liu1, J. Diamond1, M. Crespo1, S. Prenner1, V. Potluri1, C. Bermudez1, H. Mentch1, M. Moore2, B. Besharatian1, D. Goldberg3, F. Barg1, P. Reese1

1University of Pennsylvania, Philadelphia, PA, 2University of London, London, United Kingdom, 3University of Miami, Miami, FL

Meeting: 2022 American Transplant Congress

Abstract number: 555

Keywords: Hepatitis C, Informed consent, Organ Selection/Allocation, Psychosocial

Topic: Clinical Science » Infection Disease » 27 - Non-Organ Specific: Viral Hepatitis

Session Information

Session Name: Viral Hepatitis

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:50pm-6:00pm

Location: Hynes Room 312

*Purpose: Historically, many organs from deceased donors with hepatitis C virus (HCV) infection were discarded due to stigma and challenges in treating HCV after transplant. The advent of direct acting antiviral therapies led transplant centers to conduct trials of transplanting HCV-RNA+ donor organs into HCV-negative recipients, followed by antiviral therapy. However, factors that influence candidates’ decisions to accept or decline transplant with HCV-RNA+ organs are not well understood.

*Methods: To explore patient-level perceptions, influences, and experiences that inform decision-making regarding transplant with HCV-RNA+ donor organs, we conducted a qualitative semi-structured interview study embedded within three clinical trials involving transplantation of lungs or kidneys from HCV-RNA+ donors into HCV-negative recipients. The study was conducted June 2019 – March 2021.

*Results: Forty-four HCV-negative waitlisted patients participated in the qualitative study, among whom 33 enrolled in a trial and 11 declined to join a trial. Participants had diverse ways of thinking about risk and that diversity contributed to how they made decisions. Three approaches to decision-making about HCV-RNA transplant emerged: positivist (meaning that decisions must be backed up by scientific/experimental evidence), risk-benefit analyses, and instinctual response. The Table presents quotes that exemplify these three approaches to decisions. Moreover, most participants relied on multiple decision-making approaches either simultaneously or sequentially.

*Conclusions: A better understanding of how different decisional models influence patients’ decisions about transplant with organs from HCV-infected donors may promote shared decision-making among transplant patients and providers. These detailed findings may also be applicable to decision-making with other types of higher-risk organs.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Schnellinger E, Saine E, Liu M, Diamond J, Crespo M, Prenner S, Potluri V, Bermudez C, Mentch H, Moore M, Besharatian B, Goldberg D, Barg F, Reese P. Decision-Making Among HCV-Negative Transplant Candidates Offered Organs from Donors with HCV Infection [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/decision-making-among-hcv-negative-transplant-candidates-offered-organs-from-donors-with-hcv-infection/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences